
Critical Care Therapeutics Market by Drug Class (Albumin, Antithrombin Concentrates, Factor XIII Concentrates), Application (Acute Coronary Syndrome, Atrial Fibrillation, Coronary Angioplasty) - Global Forecast 2024-2030
Description
Critical Care Therapeutics Market by Drug Class (Albumin, Antithrombin Concentrates, Factor XIII Concentrates), Application (Acute Coronary Syndrome, Atrial Fibrillation, Coronary Angioplasty) - Global Forecast 2024-2030
The Critical Care Therapeutics Market size was estimated at USD 4.77 billion in 2023 and expected to reach USD 5.03 billion in 2024, at a CAGR 5.39% to reach USD 6.90 billion by 2030.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Critical Care Therapeutics Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Critical Care Therapeutics Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Critical Care Therapeutics Market, highlighting leading vendors and their innovative profiles. These include Abeona Therapeutics Inc., ADMA Biologics, Inc., Albumedix Ltd. by Sartorius AG, Asklepios BioPharmaceutical, Inc., Aspen Group, Bio Products Laboratory Ltd., BioDelivery Sciences International, Inc., Biotest AG, CSL Limited, Grifols SA, Kedrion Spa, Novartis AG, Octapharma AG, Shanghai RAAS, and Takeda Pharmaceutical Co. Ltd..
Market Segmentation & Coverage
This research report categorizes the Critical Care Therapeutics Market to forecast the revenues and analyze trends in each of the following sub-markets:
Drug Class
Albumin
Antithrombin Concentrates
Factor XIII Concentrates
Fibrinogen Concentrates
Prothrombin Complex Concentrates
Application
Acute Coronary Syndrome
Atrial Fibrillation
Coronary Angioplasty
Deep Vein Thrombosis
Hemodialysis
Pulmonary Embolism
Surgeries
Region
Americas
Argentina
Brazil
Canada
Mexico
United States
California
Florida
Illinois
New York
Ohio
Pennsylvania
Texas
Asia-Pacific
Australia
China
India
Indonesia
Japan
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam
Europe, Middle East & Africa
Denmark
Egypt
Finland
France
Germany
Israel
Italy
Netherlands
Nigeria
Norway
Poland
Qatar
Russia
Saudi Arabia
South Africa
Spain
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom
The report offers valuable insights on the following aspects:
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
The report addresses key questions such as:
1. What is the market size and forecast of the Critical Care Therapeutics Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Critical Care Therapeutics Market?
3. What are the technology trends and regulatory frameworks in the Critical Care Therapeutics Market?
4. What is the market share of the leading vendors in the Critical Care Therapeutics Market?
5. Which modes and strategic moves are suitable for entering the Critical Care Therapeutics Market?
Note: PDF & Excel + Online Access - 1 Year
Table of Contents
183 Pages
- 1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Language
- 1.6. Limitations
- 1.7. Assumptions
- 1.8. Stakeholders
- 2. Research Methodology
- 2.1. Define: Research Objective
- 2.2. Determine: Research Design
- 2.3. Prepare: Research Instrument
- 2.4. Collect: Data Source
- 2.5. Analyze: Data Interpretation
- 2.6. Formulate: Data Verification
- 2.7. Publish: Research Report
- 2.8. Repeat: Report Update
- 3. Executive Summary
- 4. Market Overview
- 4.1. Introduction
- 4.2. Critical Care Therapeutics Market, by Region
- 5. Market Insights
- 5.1. Market Dynamics
- 5.1.1. Drivers
- 5.1.1.1. Rising geriatric population worldwide and increase in prevalence of chronic diseases
- 5.1.1.2. Adoption of digitization trends and illness due to sedentary lifestyle
- 5.1.1.3. Large investments in the healthcare sector for modern medical treatments facilities
- 5.1.2. Restraints
- 5.1.2.1. High cost of therapeutics
- 5.1.3. Opportunities
- 5.1.3.1. Government activities and support for implementing critical care diagnostics
- 5.1.3.2. Rising remote communications between diagnostics and laboratories
- 5.1.4. Challenges
- 5.1.4.1. Lack of skilled professionals
- 5.2. Market Segmentation Analysis
- 5.3. Market Trend Analysis
- 5.4. Cumulative Impact of High Inflation
- 5.5. Porter’s Five Forces Analysis
- 5.5.1. Threat of New Entrants
- 5.5.2. Threat of Substitutes
- 5.5.3. Bargaining Power of Customers
- 5.5.4. Bargaining Power of Suppliers
- 5.5.5. Industry Rivalry
- 5.6. Value Chain & Critical Path Analysis
- 5.7. Regulatory Framework
- 6. Critical Care Therapeutics Market, by Drug Class
- 6.1. Introduction
- 6.2. Albumin
- 6.3. Antithrombin Concentrates
- 6.4. Factor XIII Concentrates
- 6.5. Fibrinogen Concentrates
- 6.6. Prothrombin Complex Concentrates
- 7. Critical Care Therapeutics Market, by Application
- 7.1. Introduction
- 7.2. Acute Coronary Syndrome
- 7.3. Atrial Fibrillation
- 7.4. Coronary Angioplasty
- 7.5. Deep Vein Thrombosis
- 7.6. Hemodialysis
- 7.7. Pulmonary Embolism
- 7.8. Surgeries
- 8. Americas Critical Care Therapeutics Market
- 8.1. Introduction
- 8.2. Argentina
- 8.3. Brazil
- 8.4. Canada
- 8.5. Mexico
- 8.6. United States
- 9. Asia-Pacific Critical Care Therapeutics Market
- 9.1. Introduction
- 9.2. Australia
- 9.3. China
- 9.4. India
- 9.5. Indonesia
- 9.6. Japan
- 9.7. Malaysia
- 9.8. Philippines
- 9.9. Singapore
- 9.10. South Korea
- 9.11. Taiwan
- 9.12. Thailand
- 9.13. Vietnam
- 10. Europe, Middle East & Africa Critical Care Therapeutics Market
- 10.1. Introduction
- 10.2. Denmark
- 10.3. Egypt
- 10.4. Finland
- 10.5. France
- 10.6. Germany
- 10.7. Israel
- 10.8. Italy
- 10.9. Netherlands
- 10.10. Nigeria
- 10.11. Norway
- 10.12. Poland
- 10.13. Qatar
- 10.14. Russia
- 10.15. Saudi Arabia
- 10.16. South Africa
- 10.17. Spain
- 10.18. Sweden
- 10.19. Switzerland
- 10.20. Turkey
- 10.21. United Arab Emirates
- 10.22. United Kingdom
- 11. Competitive Landscape
- 11.1. FPNV Positioning Matrix
- 11.2. Market Share Analysis, By Key Player
- 11.3. Competitive Scenario Analysis, By Key Player
- 12. Competitive Portfolio
- 12.1. Key Company Profiles
- 12.1.1. Abeona Therapeutics Inc.
- 12.1.2. ADMA Biologics, Inc.
- 12.1.3. Albumedix Ltd. by Sartorius AG
- 12.1.4. Asklepios BioPharmaceutical, Inc.
- 12.1.5. Aspen Group
- 12.1.6. Bio Products Laboratory Ltd.
- 12.1.7. BioDelivery Sciences International, Inc.
- 12.1.8. Biotest AG
- 12.1.9. CSL Limited
- 12.1.10. Grifols SA
- 12.1.11. Kedrion Spa
- 12.1.12. Novartis AG
- 12.1.13. Octapharma AG
- 12.1.14. Shanghai RAAS
- 12.1.15. Takeda Pharmaceutical Co. Ltd.
- 12.2. Key Product Portfolio
- 13. Appendix
- 13.1. Discussion Guide
- 13.2. License & Pricing
- FIGURE 1. CRITICAL CARE THERAPEUTICS MARKET RESEARCH PROCESS
- FIGURE 2. CRITICAL CARE THERAPEUTICS MARKET SIZE, 2023 VS 2030
- FIGURE 3. CRITICAL CARE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
- FIGURE 4. CRITICAL CARE THERAPEUTICS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
- FIGURE 5. CRITICAL CARE THERAPEUTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 6. CRITICAL CARE THERAPEUTICS MARKET DYNAMICS
- FIGURE 7. CRITICAL CARE THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2023 VS 2030 (%)
- FIGURE 8. CRITICAL CARE THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 9. CRITICAL CARE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
- FIGURE 10. CRITICAL CARE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 11. AMERICAS CRITICAL CARE THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 12. AMERICAS CRITICAL CARE THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 13. UNITED STATES CRITICAL CARE THERAPEUTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
- FIGURE 14. UNITED STATES CRITICAL CARE THERAPEUTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 15. ASIA-PACIFIC CRITICAL CARE THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 16. ASIA-PACIFIC CRITICAL CARE THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 17. EUROPE, MIDDLE EAST & AFRICA CRITICAL CARE THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 18. EUROPE, MIDDLE EAST & AFRICA CRITICAL CARE THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 19. CRITICAL CARE THERAPEUTICS MARKET, FPNV POSITIONING MATRIX, 2023
- FIGURE 20. CRITICAL CARE THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2023
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.